Ricevi le ultime notizie sulle azioni Olema Pharmaceuticals con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di OLMA

Ultime notizie per

OLEMA PHARMACEUTICALS INC

Olema Pharmaceuticals

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

MODV

OLMA

Le azioni sanitarie più promettenti da considerare per il quarto trimestre, con valutazioni attuali e proiezioni di crescita.

Le 3 azioni sanitarie da comprare ora: le migliori opportunità

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals inc

Press Releases

Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Earnings

Olema Oncology Reports Second Quarter 2025 Financial and Operating Results

Small Cap

Opinion

Biotech Stocks Rally as Oncology Market Targets $866B by 2034

Olema Oncology to Participate in Upcoming Investor Conferences

Health Care

Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer

IOBT

ONCY

PDSB

PRPH

TSX:ONC

Absci

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

Akebia Therapeutics

CareDx

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Erasca

Gyre Therapeutics

I-MAB

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Inventiva S.A. - American Depository Shares

Inventiva

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharmaceuticals

Kodiak Sciences

Keros Therapeutics

MeiraGTx Hldgs

Monopar Therapeutics

Myriad Genetics

Nurix Therapeutics

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Regenxbio

Rezolute

Savara

Tango Therapeutics

Tyra Biosciences

UroGen Pharma

Guggenheim

Oppenheimer

JP Morgan

Citigroup

Goldman Sachs

Comments

Olema Pharmaceuticals Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO